SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-071576
Filing Date
2024-08-22
Accepted
2024-08-21 20:04:34
Documents
14
Period of Report
2024-08-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea021207901-8k_anewmed.htm   iXBRL 8-K 25767
  Complete submission text file 0001213900-24-071576.txt   242555

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE wena-20240816.xsd EX-101.SCH 3488
3 XBRL DEFINITION FILE wena-20240816_def.xml EX-101.DEF 26510
4 XBRL LABEL FILE wena-20240816_lab.xml EX-101.LAB 36424
5 XBRL PRESENTATION FILE wena-20240816_pre.xml EX-101.PRE 25134
16 EXTRACTED XBRL INSTANCE DOCUMENT ea021207901-8k_anewmed_htm.xml XML 5471
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
ANEW Medical, Inc. (Filer) CIK: 0001907223 (see all company filings)

IRS No.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 241229876
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)